Abstract
The method of Health Technology Assessment (HTA) has been applied to assess the effectiveness and the efficacy of Home Monitoring (HM) as model of continuity of care for patient suffering from congestive heart failure (CHF). We compare HM to other model of care: ambulatory follow-up (benchmark) and Disease Management Programs (DMP). The results lead to conclude that HM is more effective and efficient if compared to the benchmark, but seems to be not costeffective if compared to DMPs. This conclusion changes when pervasive remote processing is applied to the monitored parameters with the aim to precociously predict critical events. In this case HM seems to be more effective and efficient than the other models of continuity of care.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
